Literature DB >> 27774690

A nurse-led intervention improved blood-borne virus testing and vaccination in Victorian prisons.

Rebecca J Winter1,2, Bethany White3, Stuart A Kinner4,5,6, Mark Stoové1,2, Rebecca Guy7, Margaret E Hellard1,2.   

Abstract

OBJECTIVES: Testing is the first step in treatment and care for blood-borne viruses (BBVs) and sexually transmitted infections (STIs). As new treatments for viral hepatitis emerge, it is important to document effective models for BBV/STI testing. A nurse-led intervention was implemented across three prisons in Victoria to improve BBV/STI testing. We evaluated the impact of the intervention on BBV/STI testing rates and hepatitis B (HBV) vaccination for reception prisoners.
METHODS: BBV/STI testing and HBV vaccination data were collected from the medical files of 100 consecutive reception prisoners at three prisons (n=300) prior to and after the intervention was implemented.
RESULTS: BBV testing increased significantly from 21% of prisoners to 62% post-intervention. Testing for some STIs increased significantly, but remained low: 5% to 17% for chlamydia and 1% to 5% for gonorrhoea. HBV vaccination increased significantly from 2% to 19%.
CONCLUSIONS: The nurse-led intervention resulted in substantially increased testing and vaccination, demonstrating the benefits of a concerted effort to improve BBV and STI management in correctional settings. IMPLICATIONS: The availability of new treatments for hepatitis C has precipitated expansion of treatment in prisons. Improving the testing rate of prisoners, the first step in the treatment cascade, will maximise the benefits.
© 2016 Public Health Association of Australia.

Entities:  

Keywords:  diagnostic services; immunisation; prisons; sexually transmitted diseases; viral hepatitis

Mesh:

Year:  2016        PMID: 27774690     DOI: 10.1111/1753-6405.12578

Source DB:  PubMed          Journal:  Aust N Z J Public Health        ISSN: 1326-0200            Impact factor:   2.939


  6 in total

Review 1.  Hepatitis C virus (HCV) care in Canadian correctional facilities: Where are we and where do we need to be?

Authors:  Nadine Kronfli; Jane A Buxton; Lindsay Jennings; Fiona Kouyoumdjian; Alexander Wong
Journal:  Can Liver J       Date:  2019-12-10

2.  Barriers and facilitators to COVID-19 vaccine acceptability among people incarcerated in Canadian federal prisons: A qualitative study.

Authors:  David Lessard; David Ortiz-Paredes; Hyejin Park; Olivia Varsaneux; James Worthington; Nicole E Basta; Shannon E MacDonald; Bertrand Lebouché; Joseph Cox; Shainoor J Ismail; Nadine Kronfli
Journal:  Vaccine X       Date:  2022-02-19

3.  Reasons for COVID-19 vaccine refusal among people incarcerated in Canadian federal prisons.

Authors:  David Ortiz-Paredes; Olivia Varsaneux; James Worthington; Hyejin Park; Shannon E MacDonald; Nicole E Basta; Bertrand Lebouché; Joseph Cox; Shainoor J Ismail; Nadine Kronfli
Journal:  PLoS One       Date:  2022-03-09       Impact factor: 3.240

4.  Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries.

Authors:  Rob Bielen; Samya R Stumo; Rachel Halford; Klára Werling; Tatjana Reic; Heino Stöver; Geert Robaeys; Jeffrey V Lazarus
Journal:  Harm Reduct J       Date:  2018-05-11

5.  Immunization Coverage of Inmates in Spanish Prisons.

Authors:  Nancy Vicente-Alcalde; Jose Tuells; Cecilia M Egoavil; Esther Ruescas-Escolano; Cesare Altavilla; Pablo Caballero
Journal:  Int J Environ Res Public Health       Date:  2020-10-31       Impact factor: 3.390

6.  Vaccination Coverage among Prisoners: A Systematic Review.

Authors:  Nancy Vicente-Alcalde; Esther Ruescas-Escolano; Zitta Barrella Harboe; José Tuells
Journal:  Int J Environ Res Public Health       Date:  2020-10-19       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.